Lignocainum Hydrochloricum Wzf (Lidocaine Hydrochloride Monohydrate)

Lidocaine blocks voltage‑gated sodium channels on neuronal membranes, preventing the initiation and propagation of action potentials. This reversible inhibition stops nerve impulse transmission, producing a temporary loss of sensation in the area where the drug is administered.

The dose of Lignocainum Hydrochloricum Wzf is determined by the prescribing clinician based on the specific procedure, patient characteristics, and regulatory guidelines. Healthcare professionals calculate the appropriate volume and concentration to achieve effective anesthesia while minimizing toxicity.

Safety data for lidocaine use in pregnancy and lactation are limited. It may be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians should evaluate each case individually and consider alternative options when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Lidocaine offers a rapid onset of action and moderate duration, making it suitable for many regional techniques. Compared with bupivacaine, which has a longer duration but slower onset, lidocaine is preferred when a quicker block is needed. Choice of agent depends on procedural length, desired depth of anesthesia, and patient‑specific factors.

Store the product at room temperature, preferably below 25 °C, in its original sealed container. Protect it from moisture, direct sunlight, and extreme temperature fluctuations. Do not freeze the solution, and ensure the vial is kept upright to avoid contamination.

The drug is administered by qualified healthcare professionals via epidural, infiltration, or intrathecal injection. Proper aseptic technique, correct needle placement, and aspiration before injection are essential to avoid intravascular delivery and to achieve effective regional anesthesia.

Serious risks include systemic toxicity leading to seizures, cardiac arrhythmias such as ventricular tachycardia, severe hypotension, and rare allergic reactions like anaphylaxis. Prompt recognition and management of these events are critical, and resuscitation equipment should be readily available during administration.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics should avoid this product. It is also contraindicated in individuals with severe hepatic impairment, certain cardiac conduction disorders, or those taking medications that significantly increase lidocaine plasma levels without appropriate monitoring.